MARKET

SILO

SILO

Silo Pharma Inc
NASDAQ
0.8149
0.0000
0.00%
After Hours: 0.7900 -0.0249 -3.06% 16:36 05/09 EDT
OPEN
0.8480
PREV CLOSE
0.8149
HIGH
0.8480
LOW
0.8100
VOLUME
60.35K
TURNOVER
--
52 WEEK HIGH
4.500
52 WEEK LOW
0.7100
MARKET CAP
3.65M
P/E (TTM)
-0.6827
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SILO last week (0428-0502)?
Weekly Report · 6d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 05/01 21:06
Silo Pharma announces results for its preclinical study on SP-26
TipRanks · 04/30 12:27
SILO PHARMA INC - NO IMPLANT-RELATED ADVERSE EVENTS OBSERVED IN STUDY
Reuters · 04/30 12:11
SILO PHARMA’S SP-26 KETAMINE IMPLANT MEETS ALL ENDPOINTS IN FIBROMYALGIA STUDY
Reuters · 04/30 12:11
EXCLUSIVE: Silo Pharma's Investigational Ketamine Implant Hits All Endpoints In Pain Study In Animal Models
Benzinga · 04/30 11:33
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 04/28 17:05
Silo Pharma files patent application with USPTO for SPC-14
TipRanks · 04/28 11:55
More
About SILO
Silo Pharma, Inc. is a developmental stage biopharmaceutical company. It is focused on developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It is engaged in acquiring and/or developing intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs, such as psilocybin, and the potential benefits they may have in certain cases involving depression, mental health issues and neurological disorders. Its lead program, SPC-15, is an intranasal treatment targeting post-traumatic stress disorder and stress-induced anxiety disorders. Its SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Its two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis.

Webull offers Silo Pharma Inc stock information, including NASDAQ: SILO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SILO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SILO stock methods without spending real money on the virtual paper trading platform.